This story originally ran on April 22.
AB Sciex and Thermo Fisher Scientific this week separately announced collaborations to expand research into disease areas such as cancer and develop workflows for clinical proteomics.
AB Sciex said it is working with the Samuel Lunenfeld Research Institute of Mt. Sinai Hospital in Toronto on a project that will use a new mass spectrometry platform being developed by the company. The focus of the proteomics project is to improve understanding of cancer, diabetes, and heart disease.